SEC.gov | SEC Charges California-Based Bio-Rad Laboratories With FCPA Violations
Washington D.C., Nov. 3, 2014 — The Securities and Exchange Commission today charged a clinical diagnostic and life science research company based in California with violating the Foreign Corrupt Practices Act (FCPA) when its subsidiaries made improper .....